| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_TTC3_0000200 | Intron-Exon-Intron | chr21:38448236-38466390 | chr21:37075936-37094090 | 250 nt | 0.2240 |
| hsa_TTC3_0000300 | Intron-Exon-Intron | chr21:38448236-38467744 | chr21:37075936-37095444 | 250 nt | 0.2280 |
| hsa_TTC3_0000400 | Intron-Exon-Intron | chr21:38448236-38468943 | chr21:37075936-37096643 | 250 nt | 0.2520 |
| hsa_TTC3_0000500 | Intron-Exon | chr21:38448236-38470460 | chr21:37075936-37098160 | 250 nt | 0.2880 |
| hsa_TTC3_0000600 | Intron-Exon | chr21:38448236-38470512 | chr21:37075936-37098212 | 250 nt | 0.2720 |
| hsa_TTC3_0000700 | Intron-Exon-Intron | chr21:38448236-38472048 | chr21:37075936-37099748 | 250 nt | 0.2600 |
| hsa_TTC3_0000800 | Intron-Intron | chr21:38448283-38448555 | chr21:37075983-37076255 | 273 nt | 0.3150 |
| hsa_TTC3_0000900 | Intron-Exon-Intron | chr21:38448343-38468943 | chr21:37076043-37096643 | 250 nt | 0.2720 |
| hsa_TTC3_0001000 | Intron-Intron | chr21:38452779-38455676 | chr21:37080479-37083376 | 2898 nt | 0.3841 |
| hsa_chr21_0073300 | Intergenic-Intergenic | chr21:38452989-38453283 | chr21:37080689-37080983 | 295 nt | 0.3017 |
A study in humans demonstrated that the circTTC3 shows a significant decrease in the peripheral blood of Alzheimer's disease patients, suggesting its potential to distinguish this condition from other dementias [Misir et al. DOI:10.1038/s41418-022-00948-7]. In mice and rats, circTTC3 was markedly upregulated in ischemic myocardium post-myocardial infarction and counteracted hypoxia-induced ATP depletion and apoptotic death in cardiomyocytes via the miR-15b/Arl2 axis [Tian et al. DOI:10.3390/molecules26041155]. It also alleviated hypoxic injury in HaCaT cells via miR-449a/NF-κB and PI3K/AKT pathways [Huang et al. DOI:10.3390/cells11091381].